GIP AND GLP-1 RECEPTOR DUAL-AGONISTS FOR THE TREATMENT OF DIABETES

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160185837A1
SERIAL NO

14911910

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure provides GIP/GLP-1 dual agonist polypeptides for the treatment of hypoglycemic conditions, e.g., type-2 diabetes.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIMMMUNE LIMITEDMILSTEIN BUILDING GRANTA PARK CAMBRIDGE CB21 6GH

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bednarek, Maria Cambridge, GB 7 17
Collinson, Andie Cambridge, GB 1 11
Hornigold, David Cambridge, GB 1 11
O'Brien, Siobhan Cambridge, GB 4 16
Papworth, Monika Cambridge, GB 2 11
Ravn, Peter Cambridge, GB 10 76
Sermadiras, Isabelle Cambridge, GB 6 18

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation